Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aligos Therapeutics, Inc.

8.77
+1.0713.90%
Post-market: 8.800.0300+0.34%16:14 EDT
Volume:74.36K
Turnover:626.99K
Market Cap:53.95M
PE:-0.93
High:9.00
Open:7.89
Low:7.78
Close:7.70
52wk High:46.80
52wk Low:3.76
Shares:6.15M
Float Shares:2.98M
Volume Ratio:1.44
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.4728
EPS(LYR):-20.9448
ROE:-87.74%
ROA:-40.30%
PB:0.53
PE(LYR):-0.42

Loading ...

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 15

Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-Supreme Study of Alg-000184 in Subjects With Chronic Hbv Infection

THOMSON REUTERS
·
Aug 13

Aligos Therapeutics Inc - Interim Data for Phase 2 Study Projected in 2026

THOMSON REUTERS
·
Aug 13

Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection

GlobeNewswire
·
Aug 13

Aligos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 07

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 07

Aligos Therapeutics Inc expected to post a loss of $2.36 a share - Earnings Preview

Reuters
·
Aug 05

Aligos Therapeutics Inc expected to post a loss of $2.36 a share - Earnings Preview

Reuters
·
Aug 01

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

GlobeNewswire
·
Jul 31

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

TIPRANKS
·
Jul 11

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 11

Aligos Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 27

Press Release: Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

Dow Jones
·
Jun 18

BRIEF-Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Jun 13

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

TIPRANKS
·
Jun 13

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire
·
May 29

Press Release: Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal

Dow Jones
·
May 20

Aligos Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Aligos Therapeutics Inc expected to post a loss of $2.80 a share - Earnings Preview

Reuters
·
May 02

UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls

The Fly
·
May 01